INTERNATIONAL PATENT: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. FILES APPLICATION FOR "DISRUPTION OF ETS1 AND RBPJ IN T CELLS TO ENHANCE IMMUNOTHERAPY"

GENEVA, May 28 -- ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (262 Danny Thomas PlaceMemphis, Tennessee 38105-3678) filed a patent application (PCT/US2024/055492) for "DISRUPTION OF ETS1 AND RBPJ IN T CELLS TO ENHANCE IMMUNOTHERAPY" on Nov 12, 2024. With publication no. WO/2025/106420, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHI, Hongbo (c/o St. Jude Children's Research Hospital, Inc.262 Danny Thomas PlaceMemphis, Tennessee 38105), ZHOU, Peipei (c/o St. Jude Children's Research Hospital, Inc.262 Danny Thomas Place...